BioWorld Science

Sep. 17, 2018

View Archived Issues

Total surveillance leads to cell division atlas

Read More

Mutations in IRF2BPL causes neurodegeneration in humans and flies

Read More

ASD diagnosis branches out

Read More

Cancer immunotherapy could get metabolic leg up

Read More

FDA approves Ajovy for preventive treatment of migraine

Read More

AstraZeneca adopts Horizon Discovery's Edit-R crRNA libraries for genomics discovery platform

Read More

Efgartigimod phase II data in ITP support progression to phase III development

Read More

Azitra, The Jackson Laboratory awarded grant to identify compounds for treatment of skin infections

Read More

Glenmark to use Mitra's CANscript platform in support of immuno-oncology pipeline

Read More

CymaBay opens enrollment in phase III study of seladelpar for primary biliary cholangitis

Read More

Palobiofarma enrolling patients in phase I study of PBF-1129 for NSCLC

Read More

Gilead Sciences and Precision BioSciences collaborate to develop therapies against HBV

Read More

MaxCyte studies MCY-M11 in phase I for advanced ovarian cancer and peritoneal mesothelioma

Read More

Zhejiang Beta Pharma patents fibroblast growth factor receptor inhibitors

Read More

AbbVie presents novel optimized GABA-B PAMs with efficacy in animal models of seizure

Read More

DGMIF presents DN-200434 for ATC radioiodine therapy improvement

Read More

Strategic alliance between Bayer and Evotec results in the discovery of BAY-2395840

Read More

Targeting alpha-4 integrin alleviates allergic conjunctivitis in animal models

Read More

First phase I data presented for inhaled pirfenidone

Read More

Bristol-Myers Squibb initiates two phase III trials of BMS-986165 in plaque psoriasis

Read More

Integrin alphaVbeta6 PET tracer shows promise for assessment of interstitial lung disease

Read More

Phase II data presented for CFTR potentiator QBW-251

Read More